Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine

NCT03939312 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
685
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergan